{"id":"https://openalex.org/W2007431371","doi":"https://doi.org/10.1021/jm049882t","title":"Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors","display_name":"Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors","publication_year":2004,"publication_date":"2004-06-17","ids":{"openalex":"https://openalex.org/W2007431371","doi":"https://doi.org/10.1021/jm049882t","mag":"2007431371","pmid":"https://pubmed.ncbi.nlm.nih.gov/15239665"},"language":"en","primary_location":{"id":"doi:10.1021/jm049882t","doi":"https://doi.org/10.1021/jm049882t","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm049882t","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018070511","display_name":"Francisco Caturla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco Caturla","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034936331","display_name":"Juan\u2010Miguel Jimenez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan-Miguel Jim\u00e9nez","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088143432","display_name":"N\u00faria Godessart","orcid":"https://orcid.org/0000-0003-3546-4924","observed_orcids":["https://orcid.org/0000-0003-3546-4924"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"N\u00faria Godessart","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110622523","display_name":"Merce Amat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Merc\u00e8 Amat","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alvaro C\u00e1rdenas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alvaro C\u00e1rdenas","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043555457","display_name":"L\u00eddia Soca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"L\u00eddia Soca","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108533689","display_name":"Jordi Beleta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jordi Beleta","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059361532","display_name":"Hamish Ryder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Hamish Ryder","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067471047","display_name":"M. Crespo","orcid":"https://orcid.org/0000-0001-5716-6333","observed_orcids":["https://orcid.org/0000-0001-5716-6333"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda I. Crespo","raw_affiliation_strings":["Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall Prodesfarma S.A., Research Center, Cardener 68-74, 08024 Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210122008"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.0248,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.84199101,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"47","issue":"15","first_page":"3874","last_page":"3886"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6669999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6669999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.2551000118255615,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","score":0.05119999870657921,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7910000085830688},{"id":"https://openalex.org/keywords/phenoxy-substituents","display_name":"phenoxy substituents","score":0.8080000281333923},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/anti-arthritic-activity","display_name":"anti-arthritic activity","score":0.8659999966621399},{"id":"https://openalex.org/keywords/analgesic-activity","display_name":"analgesic activity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cox-2-selectivity","display_name":"COX-2 selectivity","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9218164086341858},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.6335368752479553},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.5891218185424805},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.53414386510849},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5043190717697144},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.4515964686870575},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3249870538711548},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.27345502376556396},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23685410618782043},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm049882t","doi":"https://doi.org/10.1021/jm049882t","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm049882t","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15239665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15239665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1902187490","https://openalex.org/W1991725559","https://openalex.org/W2015875329","https://openalex.org/W2033498682","https://openalex.org/W2051686420","https://openalex.org/W2061333828","https://openalex.org/W2075421196","https://openalex.org/W2078736915","https://openalex.org/W2105318758","https://openalex.org/W2119811389","https://openalex.org/W2147174959","https://openalex.org/W2950196349","https://openalex.org/W3192767093"],"related_works":["https://openalex.org/W2033211868","https://openalex.org/W2174015249","https://openalex.org/W2093820201","https://openalex.org/W2015875329","https://openalex.org/W1983589789","https://openalex.org/W2083848358","https://openalex.org/W2045656489","https://openalex.org/W2069901076","https://openalex.org/W2950196349","https://openalex.org/W2016361268"],"abstract_inverted_index":{"A":[0,73],"series":[1],"of":[2,28,53,76,85,92,100],"2-phenylpyran-4-ones":[3],"were":[4,34],"prepared":[5],"and":[6,25,30,66,103,133,141],"evaluated":[7],"for":[8,138],"their":[9,101,107],"ability":[10],"to":[11],"inhibit":[12],"cyclooxygenase-2":[13],"(COX-2).":[14],"Extensive":[15],"structure-activity":[16],"relationship":[17],"work":[18],"was":[19,95],"carried":[20],"out":[21],"within":[22,70],"this":[23,126],"series,":[24,128],"a":[26,38,54,115,117],"number":[27],"potent":[29],"selective":[31],"COX-2":[32,48],"inhibitors":[33],"identified.":[35],"Compounds":[36],"having":[37],"p-methylsulfone":[39],"group":[40,75],"at":[41,58],"the":[42,46,63,71,98],"2-phenyl":[43],"ring":[44,57],"showed":[45],"best":[47],"inhibitory":[49],"activity.":[50],"The":[51,87],"introduction":[52],"substituted":[55],"phenoxy":[56],"position":[59],"3":[60],"enhanced":[61],"both":[62],"in":[64,67,81,88,110,123],"vitro":[65],"vivo":[68,89],"activity":[69,80,91],"series.":[72],"selected":[74,137],"3-phenoxypyran-4-ones":[77],"exhibited":[78],"excellent":[79],"an":[82],"experimental":[83],"model":[84],"pyresis.":[86],"antiinflammatory":[90],"these":[93],"compounds":[94,129],"confirmed":[96],"with":[97,114],"evaluation":[99],"antiarthritic":[102],"analgesic":[104],"effectiveness.":[105],"Moreover,":[106],"pharmacokinetic":[108],"profile":[109],"rats":[111],"is":[112],"compatible":[113],"once":[116],"day":[118],"administration":[119],"by":[120],"oral":[121],"route":[122],"humans.":[124],"Within":[125],"novel":[127],"21,":[130],"31,":[131],"34,":[132],"35":[134],"have":[135],"been":[136],"further":[139],"preclinical":[140],"clinical":[142],"evaluation.":[143]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}